RORβ modulates a gene program that is protective against articular cartilage damage

Area of Science:

• Biochemistry
• Cell Biology
• Orthopedics

Background:

• Osteoarthritis (OA) is the most common chronic joint disease, affecting over 65s and causing disability.
• Current OA treatments primarily manage pain and swelling, lacking disease-modifying capabilities.
• The precise pathogenesis of OA and effective cartilage protection strategies remain elusive.

Purpose of the Study:

• To investigate the role of RORβ in chondrogenesis and OA development.
• To determine how RORβ influences specific gene expression programs related to cartilage health.
• To explore RORβ's impact on key signaling pathways involved in OA pathogenesis.

Main Methods:

• Stable expression of RORβ in cultured cells.
• Analysis of gene expression patterns, focusing on FGF receptors (FGFR1, FGFR3).
• Assessment of downstream signaling pathways, including ERK1/2-MAPK and AKT.

Main Results:

• RORβ expression altered gene programs supporting chondrogenesis and OA protection.
• RORβ modulated the ratio of FGFR1 (cartilage destruction) to FGFR3 (cartilage protection) expression.
• ERK1/2-MAPK signaling was suppressed, while AKT signaling was enhanced by RORβ.

Conclusions:

• RORβ plays a critical role in chondrogenesis and cartilage protection.
• RORβ's influence on FGFR and MAPK/AKT signaling pathways is key to its protective effects.
• Targeting RORβ expression in chondrocytes may offer novel disease-modifying OA therapies.